Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » JP Morgan

JP Morgan

Jan 14, 2021

JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Exact Sciences discussed new Cologuard data; Danaher reviewed Cepheid's 2020 performance; and NanoString talked about forthcoming spatial biology products.

Jan 13, 2021

JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

Qiagen's CEO discussed the company's focus on specific growth drivers, while Invitae's CEO talked about pandemic-related challenges in its genetic testing business.

Jan 13, 2021

At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing

Last year, the company processed more than 1 million tests, most of them for its reproductive health business, but interest in Prospera and Signatera is growing. 

Jan 12, 2021

Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition

Premium

Hologic said the acquisition of Biotheranostics will give it a company that operates in markets that are adjacent and complementary to its own.

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Among firms presenting on the first day, 10x Genomics revealed it is developing a new high-throughput Chromium instrument, and Guardant plans to launch a comprehensive tissue sequencing assay.

Jan 11, 2021

PerkinElmer CEO Talks COVID-19, Long-Term Outlook at JP Morgan

The company anticipates total revenues of $3.9 billion for 2020, including $1 billion from its COVID-19-related business.

Jan 05, 2021

Haven Folds

The Wall Street Journal reports that the company launched by Amazon, Berkshire Hathaway, and JPMorgan Chase to transform healthcare is closing.

Dec 03, 2020

Twist Bioscience Prices Upsized $300M Public Offering

Originally, the company had said it was planning to offer $250 million worth of shares in the offering, which is expected to close Dec. 7.

Dec 02, 2020

Twist Bioscience Proposes $250M Public Offering

Included in the offering — Twist Bioscience's third this year — are 75,000 shares of common stock offered by certain selling shareholders.

Nov 03, 2020

Pacific Biosciences Gears Up For Commercial, R&D Push With Eye Toward Collaborations

Premium

In their first conference call with investors, PacBio's new CEO and CFO laid out a strategic plan for the company as it weathers the COVID-19 pandemic.

Pages

The Scan

Boosting Viral Surveillance

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

California Strain

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

Nucleic Acids Research Studies on Pan-Cancer MiRNA Biogenesis Mutations, Skeletal Methylation, More

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

What's Popular?

In JP Morgan

  1. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.